C.M. Laumont et al., “Noncoding regions are the main source of targetable tumor-specific antigens,” Sci Transl Med, 10:eaau5516, 2019. In pursuit of safe and effective cancer therapies, researchers ...

Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...

To look for telltale chemical patterns of cancer, Mihaela Žigman and colleagues tested a technique called electric-field molecular fingerprinting that uses pulsed infrared light to profile complex ...

Carisma Therapeutics is developing a unique, differentiated immuno-oncology (IO) treatment for solid tumors based on chimeric antigen receptor macrophages (CAR-M). Current IO treatments have ...

These newly recognized cancer-specific proteins, or antigens, could speed the development of potent immunotherapies that ...

The antibody 7E11 binds to the intracellular epitope of PSMA and can reach this only when the cell membrane is damaged. In this case, the tumor on the right was irradiated; the left one was not. The ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...

Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer screenings, and shares rose Friday.